NP / PA
Nashville Pediatric Providers, LLC
Nashville Pediatric Providers, LLC was paid $19.78M by Medicaid between Jan 2018 and Dec 2024, across 109 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoNASHVILLE PEDIATRIC PROVIDERS, LLC
NASHVILLE, TN 37211
NASHVILLE, TN 37211
33aNPI1992144380assigned 06/18/2013
33bProvider typePediatric Nurse Practitioner
28Total paid$19.78M
24GClaims921,654
24DCodes billed109
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Tennessee
Rank by total paid#2 of 70
Median peer was paid$60K
This provider vs. median327×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80,594 | $1.60M | |
| 2019 | 115,639 | $2.23M | |
| 2020 | 113,790 | $2.18M | |
| 2021 | 147,259 | $3.12M | |
| 2022 | 163,046 | $3.61M | |
| 2023 | 167,140 | $3.86M | |
| 2024incomplete | 134,186 | $3.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 46,395 | 41,886 | $2.92M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 66,334 | 60,482 | $2.76M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 97,093 | 57,277 | $2.49M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 11% | 125,603 | 73,439 | $2.09M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.4% | 24,504 | 21,176 | $1.67M |
| 96160 | 6.6% | 112,680 | 61,814 | $1.30M | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.4% | 20,871 | 17,483 | $1.27M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.6% | 16,420 | 14,588 | $1.10M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 4.1% | 22,109 | 20,474 | $817K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 9,569 | 8,213 | $710K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.9% | 8,872 | 2,527 | $378K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 29,985 | 13,990 | $322K |
97 more codes
| 92551 | 1.3% | 37,112 | $249K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 31,184 | $241K |
| 99177 | 1.1% | 40,600 | $219K | |
| 99401 | <1% | 6,360 | $132K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,688 | $120K |
| 99173 | <1% | 26,057 | $98K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,694 | $69K |
| 69210 | <1% | 2,019 | $68K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,127 | $49K |
| 83655 | <1% | 5,662 | $47K | |
| 99381 | <1% | 717 | $46K | |
| D1206 | Topical application of fluoride varnish | <1% | 3,114 | $42K |
| 0002A | <1% | 1,006 | $40K | |
| 96127 | <1% | 9,663 | $38K | |
| 0001A | <1% | 927 | $35K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 424 | $35K |
| 92523 | <1% | 287 | $34K | |
| 0072A | <1% | 874 | $34K | |
| 90670 | <1% | 10,888 | $31K | |
| 0071A | <1% | 735 | $27K | |
| 90480 | <1% | 670 | $27K | |
| D0190 | <1% | 3,133 | $24K | |
| 85018 | <1% | 11,953 | $20K | |
| 90677 | <1% | 3,158 | $20K | |
| 90651 | <1% | 2,857 | $20K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,343 | $19K |
| 90461 | <1% | 24,251 | $13K | |
| 90680 | <1% | 9,596 | $11K | |
| 90686 | <1% | 20,520 | $11K | |
| 90671 | <1% | 2,455 | $11K | |
| 90698 | <1% | 6,457 | $8K | |
| 0112A | <1% | 205 | $8K | |
| 0004A | <1% | 159 | $6K | |
| 90697 | <1% | 2,332 | $6K | |
| 0111A | <1% | 160 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 85 | $5K |
| 90619 | <1% | 977 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 338 | $4K |
| 0082A | <1% | 105 | $4K | |
| 90716 | <1% | 2,405 | $4K | |
| 0081A | <1% | 90 | $4K | |
| 0124A | <1% | 90 | $3K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 577 | $3K |
| 90734 | <1% | 705 | $3K | |
| 90633 | <1% | 6,825 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 957 | $3K |
| 36416 | <1% | 2,591 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,390 | $3K |
| 99383 | <1% | 31 | $2K | |
| 0154A | <1% | 62 | $2K | |
| 90688 | <1% | 7,058 | $2K | |
| 96161 | <1% | 213 | $2K | |
| 90710 | <1% | 341 | $2K | |
| 90621 | <1% | 196 | $2K | |
| 90707 | <1% | 2,346 | $2K | |
| 0164A | <1% | 45 | $2K | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 114 | $2K |
| 87807 | <1% | 211 | $1K | |
| 99384 | <1% | 14 | $1K | |
| 81003 | <1% | 822 | $1K | |
| 90744 | <1% | 3,231 | $1K | |
| 99382 | <1% | 14 | $1K | |
| 94664 | <1% | 107 | $1K | |
| 96381 | <1% | 55 | $906.77 | |
| 90696 | <1% | 411 | $857.58 | |
| 90756 | <1% | 1,573 | $805.66 | |
| 90656 | <1% | 1,251 | $774.67 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 79 | $730.13 |
| 90620 | <1% | 58 | $655.63 | |
| 0083A | <1% | 16 | $557.72 | |
| 81001 | <1% | 259 | $520.87 | |
| 86308 | <1% | 135 | $375.87 | |
| 90715 | <1% | 242 | $331.09 | |
| 94760 | <1% | 660 | $162.68 | |
| 94761 | <1% | 285 | $133.74 | |
| 90700 | <1% | 666 | $115.60 | |
| 90674 | <1% | 136 | $67.11 | |
| 90648 | <1% | 582 | $42.87 | |
| 90661 | <1% | 233 | $40.33 | |
| 91300 | <1% | 2,356 | $40.20 | |
| 90658 | <1% | 420 | $29.85 | |
| 90685 | <1% | 1,154 | $24.78 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 327 | $14.22 |
| 90687 | <1% | 486 | $11.00 | |
| 99000 | <1% | 8,041 | $9.14 | |
| 90381 | <1% | 55 | $0.27 | |
| 91312 | <1% | 90 | $0.20 | |
| 90657 | <1% | 405 | $0.09 | |
| 91307 | 0% | 1,822 | $0.00 | |
| 91316 | 0% | 62 | $0.00 | |
| 91318 | 0% | 13 | $0.00 | |
| 91315 | 0% | 62 | $0.00 | |
| 91319 | 0% | 12 | $0.00 | |
| 91311 | 0% | 458 | $0.00 | |
| 91321 | 0% | 167 | $0.00 | |
| 91308 | 0% | 293 | $0.00 | |
| 91320 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANFILIPPO, JOSEPH (OWNER)